UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 142

Sortiert nach

A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma

Thyroid (New York, N.Y.), 2016-01, Vol.26 (1), p.144

2016

Link zum Volltext

Verfügbarkeit prüfen

Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine

The journal of clinical endocrinology and metabolism, 2016-07, Vol.101 (7), p.2692-2700

2016

Link zum Volltext

Verfügbarkeit prüfen

Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6–NTRK3 fusion

Modern pathology, 2016-09, Vol.29 (9), p.985-995

2016

Link zum Volltext

Verfügbarkeit prüfen

Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance

JAMA otolaryngology-- head & neck surgery, 2017-10, Vol.143 (10), p.1015

2017

Link zum Volltext

Verfügbarkeit prüfen

Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapy

Cancer, 2011-10, Vol.117 (19), p.4439-4446

2011

Link zum Volltext

Verfügbarkeit prüfen

Response to Therapy Status Is an Excellent Predictor of Pregnancy-Associated Structural Disease Progression in Patients Previously Treated for Differentiated Thyroid Cancer

Thyroid (New York, N.Y.), 2017-03, Vol.27 (3), p.396

2017

Link zum Volltext

Verfügbarkeit prüfen

Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer

Clinical endocrinology (Oxford), 2011-07, Vol.75 (1), p.112-119

2011

Link zum Volltext

Verfügbarkeit prüfen

Invasion of a Recurrent Laryngeal Nerve from Small Well-Differentiated Papillary Thyroid Cancers: Patient Selection Implications for Active Surveillance

Thyroid (New York, N.Y.), 2022-02, Vol.32 (2), p.164

2022

Link zum Volltext

Verfügbarkeit prüfen

Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer

Annals of surgical oncology, 2016-02, Vol.23 (2), p.410-415

2016

Link zum Volltext

Verfügbarkeit prüfen

Time Course and Predictors of Structural Disease Progression in Pulmonary Metastases Arising from Follicular Cell-Derived Thyroid Cancer

Thyroid (New York, N.Y.), 2016-04, Vol.26 (4), p.518

2016

Link zum Volltext

Verfügbarkeit prüfen

Histopathologic characterization of radioactive iodine‐refractory fluorodeoxyglucose‐positron emission tomography‐positive thyroid carcinoma

Cancer, 2008-07, Vol.113 (1), p.48-56

2008

Link zum Volltext

Verfügbarkeit prüfen

Cost‐effectiveness analysis of papillary thyroid cancer surveillance

Cancer, 2015-12, Vol.121 (23), p.4132-4140

2015

Link zum Volltext

Verfügbarkeit prüfen

The impact of nodal status on outcome in older patients with papillary thyroid cancer

Surgery, 2014-07, Vol.156 (1), p.137-146

2014

Link zum Volltext

Verfügbarkeit prüfen

Operative management of locally advanced, differentiated thyroid cancer

Surgery, 2016-09, Vol.160 (3), p.738-746

2016

Link zum Volltext

Verfügbarkeit prüfen

SERIAL NECK ULTRASOUND IS MORE LIKELY TO IDENTIFY FALSE-POSITIVE ABNORMALITIES THAN CLINICALLY SIGNIFICANT DISEASE IN LOW-RISK PAPILLARY THYROID CANCER PATIENTS

Endocrine practice, 2015-12, Vol.21 (12), p.1372-1379

2015

Link zum Volltext

Verfügbarkeit prüfen

Recombinant human thyroid stimulating hormone-assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence

Thyroid (New York, N.Y.), 2012-10, Vol.22 (10), p.1007

2012

Link zum Volltext

Verfügbarkeit prüfen

Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer

Thyroid (New York, N.Y.), 2014-11, Vol.24 (11), p.1594

2014

Link zum Volltext

Verfügbarkeit prüfen

Observation of clinically negative central compartment lymph nodes in papillary thyroid carcinoma

Surgery, 2013-12, Vol.154 (6), p.1166-1173

2013

Link zum Volltext

Verfügbarkeit prüfen

Iatrogenic hyperthyroidism does not promote weight loss or prevent ageing-related increases in body mass in thyroid cancer survivors

Clinical endocrinology (Oxford), 2012-04, Vol.76 (4), p.582-585

2012

Link zum Volltext

Verfügbarkeit prüfen

Outcome of Large Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features

Thyroid (New York, N.Y.), 2017-04, Vol.27 (4), p.512

2017

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of routine ultrasonographic surveillance of patients with low-risk papillary carcinoma of the thyroid

Surgery, 2016-05, Vol.159 (5), p.1390-1395

2016

Link zum Volltext

Verfügbarkeit prüfen

Comparable outcomes for patients with pT1a and pT1b differentiated thyroid cancer: Is there a need for change in the AJCC classification system?

Surgery, 2014-12, Vol.156 (6), p.1484-1490

2014

Link zum Volltext

Verfügbarkeit prüfen

Skeletal-Related Events due to Bone Metastases from Differentiated Thyroid Cancer

The journal of clinical endocrinology and metabolism, 2012-07, Vol.97 (7), p.2433-2439

2012

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems

Thyroid (New York, N.Y.), 2013-11, Vol.23 (11), p.1401

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 142

Suche als RSS-Feed

Aktive Filter

ThemaThyroid Cancer

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(138)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(142)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma

Dynamic Risk Stratification in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine

Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6–NTRK3 fusion

Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance

Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapy

Response to Therapy Status Is an Excellent Predictor of Pregnancy-Associated Structural Disease Progression in Patients Previously Treated for Differentiated Thyroid Cancer

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors

Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer

Invasion of a Recurrent Laryngeal Nerve from Small Well-Differentiated Papillary Thyroid Cancers: Patient Selection Implications for Active Surveillance

Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer

Time Course and Predictors of Structural Disease Progression in Pulmonary Metastases Arising from Follicular Cell-Derived Thyroid Cancer

Histopathologic characterization of radioactive iodine‐refractory fluorodeoxyglucose‐positron emission tomography‐positive thyroid carcinoma

Cost‐effectiveness analysis of papillary thyroid cancer surveillance

The impact of nodal status on outcome in older patients with papillary thyroid cancer

Operative management of locally advanced, differentiated thyroid cancer

SERIAL NECK ULTRASOUND IS MORE LIKELY TO IDENTIFY FALSE-POSITIVE ABNORMALITIES THAN CLINICALLY SIGNIFICANT DISEASE IN LOW-RISK PAPILLARY THYROID CANCER PATIENTS

Recombinant human thyroid stimulating hormone-assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence

Multi-organ distant metastases confer worse disease-specific survival in differentiated thyroid cancer

Observation of clinically negative central compartment lymph nodes in papillary thyroid carcinoma

Iatrogenic hyperthyroidism does not promote weight loss or prevent ageing-related increases in body mass in thyroid cancer survivors

Outcome of Large Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features

Effectiveness of routine ultrasonographic surveillance of patients with low-risk papillary carcinoma of the thyroid

Comparable outcomes for patients with pT1a and pT1b differentiated thyroid cancer: Is there a need for change in the AJCC classification system?

Skeletal-Related Events due to Bone Metastases from Differentiated Thyroid Cancer

Outcomes of patients with differentiated thyroid cancer risk-stratified according to the American thyroid association and Latin American thyroid society risk of recurrence classification systems

Aktive Filter

Suchergebnisse filtern